Endocrine Metabolic

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC46-20

DiraChart Clinical Reference
Protected section 20 of 25
← Document menu
Home Care · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 20 of 25PreviousNext

16. Weak vs. strong documentation

Paired entries for this system. The left column is denial-bait; the right column is the same clinical picture written so a reviewer can see why a nurse was required.

Weak — does not survive

Why it fails

Strong — defensible

“Blood sugar fine.”

No value, no target, no pattern, no skilled judgment — a layperson observation.

“Glucose log 90–150, within individualized target 80–180; no hypos; pattern stable; insulin technique correct on observation.”

“Takes insulin.”

Records a fact, not technique assessment or effect.

“Observed insulin draw/inject: correct dose per order, site rotated, technique correct; pattern in target; no dosing errors.”

“Sugar was low.”

No value, no symptoms, no action.

“Glucose 41 with confusion and diaphoresis; glucagon given per order, recheck 96, EMS activated as mentation slow; MD notified.”

“Feet look okay.”

No skin or sensation assessment, no risk.

“Feet intact, no lesions; protective sensation absent at great toes per monofilament; daily foot-check and offloading reinforced.”

“Educated on diabetes.”

No content, no learner response.

“Glucose monitoring and hypoglycemia rescue taught; caregiver return-demonstrated glucagon correctly; sick-day rules reviewed and verbalized.”

“Sugars high.”

No pattern, no target, no action.

“Glucose 250–340 × 4 days, above individualized target; regimen not controlling; MD notified, insulin adjusted; pattern to be reassessed.”

Section NavigationPart 20 of 25PreviousNext